Mi2000 TICI - Post-market Implantation Study (TUPIS)
This Post-Market Clinical Follow-up (PMCF) investigation aims to further collect evidence on safety and performance of the Mi2000 TICI. This PMCF investigation will prospectively collect clinical data from the use of the Mi2000 TICI and related devices.
This PMCF investigation is performed on a cochlear implant system newly introduced to the market, which was previously studied in two pre-market clinical investigations. The purpose of the current clinical investigation is to collect further evidence by collecting additional clinical data on the use of the Mi2000 TICI.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Tipo de estudo
Inscrição (Estimado)
Estágio
- Não aplicável
Contactos e Locais
Contato de estudo
- Nome: Florian Schwarze, PhD
- Número de telefone: +4357788
- E-mail: studies@medel.com
Locais de estudo
-
-
-
Würzburg, Alemanha
- Ainda não está recrutando
- Universitätsklinikum Würzburg
-
Contato:
- Kristen Rak, Prof. Dr.
-
-
Bavaria
-
München, Bavaria, Alemanha, 81377
- Recrutamento
- Klinikum der Universität München, Campus Großhadern
-
Contato:
- Joachim Müller, Dr.med.
-
-
-
-
-
Liège, Bélgica, 4000
- Ainda não está recrutando
- Centre Hospitalier Universitaire de Liège, Department ORL
-
Contato:
- Philippe Lefebvre, Dr.med.
-
-
Belgium
-
Antwerp, Belgium, Bélgica, 2650
- Ainda não está recrutando
- UZA Antwerpen
-
Contato:
- Vincent van Rompaey, Prof. Dr.
-
-
-
-
Poland
-
Nadarzyn, Poland, Polônia, 05-830
- Ainda não está recrutando
- The Institute of Physiology and Pathology of Hearing
-
Contato:
- Piotr Skarzynski, Prof. Dr.
-
-
-
-
State of Vienna
-
Vienna, State of Vienna, Áustria, 1090
- Ainda não está recrutando
- AKH Wien
-
Contato:
- Christoph Arnoldner, Prof. Dr.
- E-mail: christoph.arnoldner@meduniwien.ac.at
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- Minimum age of eighteen (18) years at time of enrolment
- Bilateral sensorineural hearing loss with no or limited benefit from a hearing aid (>70 dB HL PTA4(500, 1000, 2000, 4000Hz))
- Post-lingual onset of deafness
- No or limited benefit from hearing aids for less than 10 years and an expected benefit from cochlear implantation
- A maximum score of 50% on a word test in the language of the test center in the ear to be implanted in the best aided condition
- Fluency in the test language with excellent proficiency, as appropriate to perform speech testing
- Functional auditory nerve
- General health condition, psychological and emotional condition deemed compatible with the treatment and tests performed in this study
- Pre-operative assessment according to the local professional standards
- Candidate is highly motivated and has realistic expectations about the expected benefit of the implant and shall understand the importance of returning to the implant center for regular speech processor programming, assessment sessions and training
- Realistic expectations, as deemed appropriate by the implanting surgeon/implant board
- Signed and dated informed consent before the start of any study-specific procedure
Exclusion Criteria:
-
Lack of compliance with any inclusion criterion
-
Previously having received an implant on the location chosen for placing the cochlear implant
-
Having received a hearing implant from another manufacturer than MED-EL on the contralateral ear
-
Pre-existing condition known to necessitate MRI scans after implantation of the Mi2000 TICI
-
Women being pregnant or nursing
-
The individual is known to be intolerant of the materials used in the implant or other required accessories
-
Absence of cochlear development
-
The cause of deafness is non-functionality of the auditory nerve and/or the upper auditory pathway
-
Medical contra-indications to middle ear and/or inner ear surgery, and/or anesthesia
-
External or middle ear infections are present
-
The tympanic membrane is perforated in the ear to be implanted
-
Anatomic abnormalities are present that would prevent appropriate placement of the stimulator housing in the bone of the skull, or prevent placement of the chosen electrode array into the cochlea (including ossification of the cochlea)
-
The psychological status of the individual is unstable
-
The individual has unrealistic expectations
-
Acute cholesteatoma
-
History of vestibular schwannoma
-
Unstable Meniere's disease
-
Auditory Neuropathy
-
Epilepsy not responding to treatment
-
Permanent inability and/or unwillingness to participation in post-operative care and rehabilitation
-
Known intellectual disability and/or psychological diseases
-
Participation in other pharmacological clinical trials within four weeks prior to enrolment
-
Anything that, in the opinion of the Investigator, would
- place the subject at increased risk
- preclude the subject's full compliance with or completion of the study
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: TICI recipients
Participants in this clinical investigation will be implanted with an Mi2000 TICI totally cochlear implant |
Participants in this clinical investigation will receive a totally implantable cochlear implant. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Word Test in Quiet
Prazo: Pre-op to 6 months after first fitting
|
Word recognition in quiet, on a scale from 0 to 100% correct, higher scores indicate better outcomes |
Pre-op to 6 months after first fitting
|
|
Sentence Test in Noise
Prazo: Pre-op to 6 months after first fitting
|
Oldenburg Matrix Test, results measured in dB signal-to-noise ratio (SNR) with a range of +30 to -10 dB SNR, lower values indicating better outcomes |
Pre-op to 6 months after first fitting
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Health Utility Index Mark 3 (HUI3)
Prazo: Pre-op to 6 months after first fitting
|
Health utility scale: 1.00: Perfect health. 0.00: Death. Negative values: States worse than death. |
Pre-op to 6 months after first fitting
|
|
Nijmegen Cochlear Implant Questionnaire (NCIQ)
Prazo: Pre-op to 6 months after first fitting
|
Disease specific Quality of Life, overall score is on a scale from 0 to 100, higher numbers indicating better outcomes |
Pre-op to 6 months after first fitting
|
|
Change in body sound perception
Prazo: through study completion, an average of 12 months after first fitting
|
Participant reported scale on body sound perception (0 - no disturbance to 10 - very disturbing) |
through study completion, an average of 12 months after first fitting
|
|
Change in stigma perception
Prazo: through study completion, an average of 12 months after first fitting
|
Participant reported scale on stigma perception (0 - no stigmatization to 10 - strong stigmatization) |
through study completion, an average of 12 months after first fitting
|
|
Change in comfort perception
Prazo: through study completion, an average of 12 months after first fitting
|
Participant reported scale on stigma perception (0 - not comfortable to 10 - very comfortable) |
through study completion, an average of 12 months after first fitting
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Word test in quiet
Prazo: through study completion, an average of 12 months after first fitting
|
Word recognition in quiet, on a scale from 0 to 100% correct, higher scores indicate better outcomes |
through study completion, an average of 12 months after first fitting
|
|
Sentence Test in Noise
Prazo: through study completion, an average of 12 months after first fitting
|
Oldenburg Matrix Test, results measured in dB signal-to-noise ratio (SNR) with a range of +30 to -10 dB SNR, lower values indicating better outcomes |
through study completion, an average of 12 months after first fitting
|
|
Health Utility Index Mark 3 (HUI3)
Prazo: through study completion, an average of 12 months after first fitting
|
Health utility scale: 1.00: Perfect health. 0.00: Death. Negative values: States worse than death. |
through study completion, an average of 12 months after first fitting
|
|
Nijmegen Cochlear Implant Questionnaire (NCIQ)
Prazo: through study completion, an average of 12 months after first fitting
|
Disease specific Quality of Life, overall score is on a scale from 0 to 100, higher numbers indicating better outcomes |
through study completion, an average of 12 months after first fitting
|
|
Speech, Spatial, Quality of Hearing (SSQ12)
Prazo: through study completion, an average of 12 months after first fitting
|
Speech, Spatial and Quality of hearing scale from 0 to 10, higher numbers indicating better outcomes |
through study completion, an average of 12 months after first fitting
|
|
Hearing Implant Sound Quality Index (HISQUI)
Prazo: through study completion, an average of 12 months after first fitting
|
Sound quality score ranging from 19 (very poor sound quality) to 133 (very good sound quality) |
through study completion, an average of 12 months after first fitting
|
|
Tinnitus Functional Index (TFI)
Prazo: through study completion, an average of 12 months after first fitting
|
Tinnitus questionnaire measures the severity and negative impact of tinnitus on a 0 (Not a Problem / Slight Tinnitus) to 100 (Very Big Problem / Very Severe Tinnitus) scale |
through study completion, an average of 12 months after first fitting
|
|
Audiogram
Prazo: through study completion, an average of 12 months after first fitting
|
Pure-tone air-conduction hearing thresholds will be measured in each ear. The threshold is the lowest sound level, in decibels hearing level (dB HL), at which the participant responds. The outcome is the threshold at each frequency. Higher thresholds mean poorer hearing; lower thresholds better hearing. |
through study completion, an average of 12 months after first fitting
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Diretor de estudo: Florian Schwarze, MED-EL
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Manifestações Neurológicas
- Doenças do Sistema Nervoso
- Doenças Otorrinolaringológicas
- Distúrbios da Sensação
- Doenças do ouvido
- Distúrbios da Audição
- Condições Patológicas, Sinais e Sintomas
- Sinais e sintomas
- Perda de audição
- Procedimentos cirúrgicos, operatórios
- Implante de prótese
- Procedimentos cirúrgicos otorinolaryngológicos
- Procedimentos cirúrgicos otológicos
- Implante coclear
Outros números de identificação do estudo
- MED-EL_CRD_2026_03
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
produto fabricado e exportado dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .